1994 …2020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Domenico Galetta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Observational Studies Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2020

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients

Reale, M. L., Chiari, R., Tiseo, M., Vitiello, F., Barbieri, F., Cortinovis, D., Ceresoli, G. L., Finocchiaro, G., Romano, G. D., Piovano, P. L., Del Conte, A., Borra, G., Verderame, F., Scotti, V., Nonnis, D., Galetta, D., Sergi, C., Migliorino, M. R., Tonini, G., Cecere, F. & 11 others, Berardi, R., Pino, M. S., Martelli, O., Gelibter, A., Carta, A., Vattemi, E., Pagano, M., Zullo, A., Ferrari, S., Rossi, A. & Novello, S., Feb 2020, In : Lung Cancer. 140, p. 71-79 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Observational Studies
Molecular Pathology

ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)

Chiari, R., Ricciuti, B., Landi, L., Morelli, A. M., Delmonte, A., Spitaleri, G., Cortinovis, D. L., Lamberti, G., Facchinetti, F., Pilotto, S., Verusio, C., Chella, A., Bonanno, L., Galetta, D. & Cappuzzo, F., Jan 2020, In : Clinical Lung Cancer. 21, 1, p. 15-20 6 p.

Research output: Contribution to journalArticle

Venous Thromboembolism
Non-Small Cell Lung Carcinoma
Renal Veins

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., Nov 21 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 316.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Bone and Bones
Disease-Free Survival

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience

Rihawi, K., Giannarelli, D., Galetta, D., Delmonte, A., Giavarra, M., Turci, D., Garassino, M., Tiseo, M., Barbieri, F., Panni, S. & Ardizzoni, A., Mar 2019, In : Journal of Thoracic Oncology. 14, 3, p. e57-e59

Research output: Contribution to journalLetter

Crizotinib in MET-deregulated or ROS1-rearranged pretreated non–small cell lung cancer (METROS): A phase II, prospective, multicenter, two-arms trial

Landi, L., Chiari, R., Tiseo, M., D'Inca, F., Dazzi, C., Chella, A., Delmonte, A., Bonanno, L., Giannarelli, D., Cortinovis, D. L., de Marinis, F., Borra, G., Morabito, A., Gridelli, C., Galetta, D., Barbieri, F., Grossi, F., Capelletto, E., Minuti, G., Mazzoni, F. & 8 others, Verusio, C., Bria, E., Al, G., Bruno, R., Proietti, A., Fontanini, G., Crino, L. & Cappuzzo, F., 2019, In : Clinical Cancer Research. 25, 24, p. 7312-7319 8 p.

Research output: Contribution to journalArticle